Repression of MHC class I transcription by HPV16E7 through interaction with a putative RXRβ motif and NF-κB cytoplasmic sequestration

Biochemical and Biophysical Research Communications

Volumn 388, Issue 2, 2009, Pages 383-388

  Li, Hui ^a   Zhan, TaiLan ^a   Li, Chang ^a   Liu, Mugen ^a   Wang, Qing K ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

HPV16E7; MHC class I; NF B; Transcriptional repression

Indexed keywords

I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RETINOID X RECEPTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; GENE REPRESSION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TUMOR CELL;

AMINO ACID MOTIFS; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; HISTONE DEACETYLASES; HLA-A2 ANTIGEN; HUMANS; NF-KAPPA B; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS, GENETIC; RETINOID X RECEPTOR BETA; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 69249222549     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.019     Document Type: Article

References (26)

1. Franco E.L., Schlecht N.F., and Saslow D. The epidemiology of cervical cancer. Cancer J. 9 (2003) 348-359
2. Mansur C.P., and Androphy E. Cellular transformation by papillomavirus oncoproteins. Biochem. Biophys. Acta 1155 (1993) 323-345
3. Balsitis S., Dick F., Lee D., Farrell L., Hyde R.K., Griep A.E., Dyson N., and Lambert P.F. Examination of the pRb-dependent and pRb-independent functions of E7 in vivo. J. Virol. 79 (2005) 11392-11402
4. Liu Y., Heilman S.A., Illanes D., Sluder G., and Chen J.J. p53-independent abrogation of a postmitotic checkpoint contributes to human papillomavirus E6-induced polyploidy. Cancer Res. 67 (2007) 2603-2610
5. Zinkemagel R.M., and Doherty P.C. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 27 (1979) 51-77
6. Bubeník J. MHC class I down regulation, tumour escape from immune surveillance and design of therapeutic strategies. Folia Biol. 51 (2005) 1-2
7. Koopman L.A., Corver W.E., van der Slik A.R., Giphart M.J., and Fleuren G.J. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J. Exp. Med. 191 (2000) 961-976
8. Connor M.E., Davidson S.E., Stern P.L., Arrand J.R., and West C.M.L. Evaluation of multiple biological parameters in cervical carcinoma: high macrophage infiltration in HPV-associated tumours. Int. J. Gynecol. Cancer 3 (1993) 103-109
9. Georgopoulos N.T., Proffitt J.L., and Blair G.E. Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene 19 (2000) 4930-4935
10. Li H., Ou X., Xiong J., and Wang T. HPV16E7 mediates HDAC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter. Biochem. Biophys. Res. Commun. 349 (2006) 1315-1321
11. Gobin S.J., Vanzutphen M., Woltman A.M., and van den Elsen P.J. Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J. Immunol. 163 (1999) 1428-1434
12. Gobin S.J., Peijnenburg A., Nan Eggermond M., Van Zutphen M., van den Berg R., and van den Elsen P.J. The RFX complex is crucial for the constitutive and CIITA mediated transactivation of MHC class I and beta 2-microglobulin genes. Immunity 4 (1998) 531-541
13. Spitkovsky D., Hehner S.P., Hofmann T.G., Möller A., and Schmitz M.L. The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex. J. Biol. Chem. 28 (2002) 25576-25582
14. Wells J., and Farnham P.J. Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. Methods 26 (2002) 48-56
15. Kushner D.B., and Ricciardi R.P. Reduced phosphorylation of p50 is responsible for diminished NF-κB binding to the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells. Mol. Cell. Biol. 19 (1999) 2169-2179
16. Segars J.H., Marks M.S., Hirschfeld S., Driggers P.H., Martinez E., Grippo J.F., Brown M., Wahli W., and Ozato K. Inhibition of estrogen-responsive gene activation by the retinoid X receptor beta: evidence for multiple inhibitory pathways. Mol. Cell. Biol. 13 (1993) 2258-2268
17. Miyazaki J., Appella E., and Ozato K. Negative regulation of the major histocompatibility class I gene in undifferentiated embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 83 (1986) 9537-9541
18. Johnson D.R. Locus-specific constitutive and cytokine-induced HLA class I gene expression. J. Immunol. 170 (2003) 1894-1902
19. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., and Rao A. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278 (1997) 860-866
20. Agrawal S., and Kishore M.C. MHC class I gene expression and regulation. J. Hematother. Stem Cell Res. 9 (2000) 795-812
21. Zhao B., and Ricciardi R.P. E1A is the component of the MHC class I enhancer complex that mediates HDAC chromatin repression in adenovirus-12 tumorigenic cells. Virology 352 (2006) 338-344
22. Jones J.O., and Arvin A.M. Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J. Virol. 80 (2006) 5113-5124
23. Oie K.L., and Pickup D.J. Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation. Virology 288 (2001) 175-187
24. Tartour E., Gey A., Sastre-Garau X., Pannetier C., Mosseri V., Kourilsky P., and Fridman W.H. Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma. Cancer Res. 54 (1994) 6243-6248
25. Huang S.M., and McCance D.J. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF. J. Virol. 76 (2002) 8710-8721
26. Hoffmann A., and Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 210 (2006) 171-186